Here, we reported that CCL5-deficiency dramatically inhibited S100a9 secretion in CD11bhiF4/80low TAMs, which contributed to the ability of CD11bhiF4/80low TAMsCCL5−/− in promoting the infiltration of CD8+ T cells into the central tumor area. Here, CCL5 is linked to neoplasm.